1. Adelaide Research & Scholarship

Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-7 of 7 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2020Meningococcal B vaccine and meningococcal carriage in adolescents in AustraliaMarshall, H.S.; McMillan, M.; Koehler, A.P.; Lawrence, A.; Sullivan, T.R.; MacLennan, J.M.; Maiden, M.C.J.; Ladhani, S.N.; Ramsay, M.E.; Trotter, C.; Borrow, R.; Finn, A.; Kahler, C.M.; Whelan, J.; Vadivelu, K.; Richmond, P.
2023Complex intervention to promote human papillomavirus (HPV) vaccine uptake in school settings: A cluster-randomized trialDavies, C.; Marshall, H.S.; Brotherton, J.M.L.; McCaffery, K.; Kang, M.; Macartney, K.; Garland, S.; Kaldor, J.; Zimet, G.; Skinner, S.R.; HPV.edu Study Group,
2023Real World Impact of 13vPCV in Preventing Invasive Pneumococcal Pneumonia in Australian Children: A National StudyHomaira, N.; Strachan, R.; Quinn, H.; Beggs, S.; Bhuiyan, M.; Bowen, A.; Fawcett, L.K.; gilbert, L.; Lambert, S.B.; Macartney, K.; Marshall, H.S.; Martin, A.C.; McCallum, G.; McCullagh, A.; McDonald, T.; Selvadurai, H.; McIntyre, P.; Oftadeh, S.; Ranganathan, S.; Saunders, T.; et al.
2021Effect of a school-based educational intervention about the human papillomavirus vaccine on psychosocial outcomes among adolescents: analysis of secondary outcomes of a cluster randomized trialDavies, C.; Marshall, H.S.; Zimet, G.; McCaffery, K.; Brotherton, J.M.L.; Kang, M.; Garland, S.; Kaldor, J.; McGeechan, K.; Skinner, S.R.
2022Pertussis disease and antenatal vaccine effectiveness in Australian childrenQuinn, H.E.; Comeau, J.L.; Marshall, H.S.; Elliott, E.J.; Crawford, N.W.; Blyth, C.C.; Kynaston, J.A.; Snelling, T.L.; Richmond, P.C.; Francis, J.R.; Macartney, K.K.; McIntyre, P.B.; Wood, N.J.
2022Impact of COVID-19 Containment Strategies and Meningococcal Conjugate ACWY Vaccination on Meningococcal Carriage in AdolescentsMcMillan, M.; Bednarz, J.; Leong, L.E.X.; Lawrence, A.; Marshall, H.S.
2022Safety and immunogenicity of a primary series and booster dose of the meningococcal serogroup B-factor H binding protein vaccine (MenB-FHbp) in healthy children aged 1-9 years: two phase 2 randomised, controlled, observer-blinded studies.Marshall, H.S.; Vesikari, T.; Richmond, P.C.; Wysocki, J.; Szenborn, L.; Beeslaar, J.; Maguire, J.D.; Balmer, P.; O'Neill, R.; Anderson, A.S.; Prégaldien, J.-L.; Maansson, R.; Jiang, H.-Q.; Perez, J.L.

Discover